• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global Neurological Biomarkers Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

report cover
  • 2 September 2020
  • Healthcare
  • 134 Pages
  • Report Code: 24LS-21293
  • Formate :   
Download FREE Report Sample Download PDF File

Neurological Biomarkers -MARKET ADVISORY SERVICES

Neurological Biomarkers market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Neurological Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.

Segment by Type, the Neurological Biomarkers market is segmented into
Proteomics
Genomics
Imaging
Bioinformatics
Others

Segment by Application, the Neurological Biomarkers market is segmented into
Diagnostics
Drug Discovery
Personalized Medicine
Others

Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Competitive Landscape and Neurological Biomarkers Market Share Analysis
Neurological Biomarkers market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Neurological Biomarkers product introduction, recent developments, Neurological Biomarkers sales by region, type, application and by sales channel.

The major companies include:
Thermo Fisher Scientific
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz
1 Study Coverage
1.1 Neurological Biomarkers Product Introduction
1.2 Market by Type
1.2.1 Global Neurological Biomarkers Market Size Growth Rate by Type
1.2.2 Proteomics
1.2.3 Genomics
1.2.4 Imaging
1.2.5 Bioinformatics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Neurological Biomarkers Market Size Growth Rate by Application
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Neurological Biomarkers Market Size Estimates and Forecasts
2.1.1 Global Neurological Biomarkers Revenue 2015-2026
2.1.2 Global Neurological Biomarkers Sales 2015-2026
2.2 Neurological Biomarkers Market Size by Region: 2020 Versus 2026
2.3 Neurological Biomarkers Sales by Region (2015-2026)
2.3.1 Global Neurological Biomarkers Sales by Region: 2015-2020
2.3.2 Global Neurological Biomarkers Sales Forecast by Region (2021-2026)
2.3.3 Global Neurological Biomarkers Sales Market Share by Region (2015-2026)
2.4 Neurological Biomarkers Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Neurological Biomarkers Revenue by Region: 2015-2020
2.4.2 Global Neurological Biomarkers Revenue Forecast by Region (2021-2026)
2.4.3 Global Neurological Biomarkers Revenue Market Share by Region (2015-2026)

3 Global Neurological Biomarkers by Manufacturers
3.1 Global Top Neurological Biomarkers Manufacturers by Sales
3.1.1 Global Neurological Biomarkers Sales by Manufacturer (2015-2020)
3.1.2 Global Neurological Biomarkers Sales Market Share by Manufacturer (2015-2019)
3.2 Global Top Neurological Biomarkers Manufacturers by Revenue
3.2.1 Global Neurological Biomarkers Revenue by Manufacturer (2015-2020)
3.2.2 Global Neurological Biomarkers Revenue Share by Manufacturer (2015-2020)
3.3 Global Neurological Biomarkers Price by Manufacturer (2015-2020)
3.4 Competitive Landscape
3.4.1 Key Neurological Biomarkers Manufacturers Covered: Ranking by Revenue
3.4.2 Global Neurological Biomarkers Market Concentration Ratio (CR5 and HHI) & (2015-2020)
3.4.3 Global Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Neurological Biomarkers Manufacturing Base Distribution, Product Type
3.5.1 Neurological Biomarkers Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Neurological Biomarkers Product Type
3.5.3 Date of International Manufacturers Enter into Neurological Biomarkers Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles
4.1 Thermo Fisher Scientific
4.1.1 Thermo Fisher Scientific Corporation Information
4.1.2 Thermo Fisher Scientific Description, Business Overview
4.1.3 Thermo Fisher Scientific Neurological Biomarkers Products Offered
4.1.4 Thermo Fisher Scientific Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
4.1.5 Thermo Fisher Scientific Neurological Biomarkers Revenue by Product
4.1.6 Thermo Fisher Scientific Neurological Biomarkers Revenue by Application
4.1.7 Thermo Fisher Scientific Neurological Biomarkers Revenue by Geographic Area
4.1.8 Thermo Fisher Scientific Neurological Biomarkers Revenue by Sales Channel
4.1.9 Thermo Fisher Scientific Recent Development
4.2 Merck
4.2.1 Merck Corporation Information
4.2.2 Merck Description, Business Overview
4.2.3 Merck Neurological Biomarkers Products Offered
4.2.4 Merck Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
4.2.5 Merck Neurological Biomarkers Revenue by Product
4.2.6 Merck Neurological Biomarkers Revenue by Application
4.2.7 Merck Neurological Biomarkers Revenue by Geographic Area
4.2.8 Merck Neurological Biomarkers Revenue by Sales Channel
4.2.9 Merck Recent Development
4.3 Quest Diagnostics
4.3.1 Quest Diagnostics Corporation Information
4.3.2 Quest Diagnostics Description, Business Overview
4.3.3 Quest Diagnostics Neurological Biomarkers Products Offered
4.3.4 Quest Diagnostics Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
4.3.5 Quest Diagnostics Neurological Biomarkers Revenue by Product
4.3.6 Quest Diagnostics Neurological Biomarkers Revenue by Application
4.3.7 Quest Diagnostics Neurological Biomarkers Revenue by Geographic Area
4.3.8 Quest Diagnostics Neurological Biomarkers Revenue by Sales Channel
4.3.9 Quest Diagnostics Recent Development
4.4 Abbott
4.4.1 Abbott Corporation Information
4.4.2 Abbott Description, Business Overview
4.4.3 Abbott Neurological Biomarkers Products Offered
4.4.4 Abbott Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
4.4.5 Abbott Neurological Biomarkers Revenue by Product
4.4.6 Abbott Neurological Biomarkers Revenue by Application
4.4.7 Abbott Neurological Biomarkers Revenue by Geographic Area
4.4.8 Abbott Neurological Biomarkers Revenue by Sales Channel
4.4.9 Abbott Recent Development
4.5 Roche
4.5.1 Roche Corporation Information
4.5.2 Roche Description, Business Overview
4.5.3 Roche Neurological Biomarkers Products Offered
4.5.4 Roche Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
4.5.5 Roche Neurological Biomarkers Revenue by Product
4.5.6 Roche Neurological Biomarkers Revenue by Application
4.5.7 Roche Neurological Biomarkers Revenue by Geographic Area
4.5.8 Roche Neurological Biomarkers Revenue by Sales Channel
4.5.9 Roche Recent Development
4.6 Illumina
4.6.1 Illumina Corporation Information
4.6.2 Illumina Description, Business Overview
4.6.3 Illumina Neurological Biomarkers Products Offered
4.6.4 Illumina Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
4.6.5 Illumina Neurological Biomarkers Revenue by Product
4.6.6 Illumina Neurological Biomarkers Revenue by Application
4.6.7 Illumina Neurological Biomarkers Revenue by Geographic Area
4.6.8 Illumina Recent Development
4.7 Bio-Rad Laboratories
4.7.1 Bio-Rad Laboratories Corporation Information
4.7.2 Bio-Rad Laboratories Description, Business Overview
4.7.3 Bio-Rad Laboratories Neurological Biomarkers Products Offered
4.7.4 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
4.7.5 Bio-Rad Laboratories Neurological Biomarkers Revenue by Product
4.7.6 Bio-Rad Laboratories Neurological Biomarkers Revenue by Application
4.7.7 Bio-Rad Laboratories Neurological Biomarkers Revenue by Geographic Area
4.7.8 Bio-Rad Laboratories Recent Development
4.8 QIAGEN
4.8.1 QIAGEN Corporation Information
4.8.2 QIAGEN Description, Business Overview
4.8.3 QIAGEN Neurological Biomarkers Products Offered
4.8.4 QIAGEN Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
4.8.5 QIAGEN Neurological Biomarkers Revenue by Product
4.8.6 QIAGEN Neurological Biomarkers Revenue by Application
4.8.7 QIAGEN Neurological Biomarkers Revenue by Geographic Area
4.8.8 QIAGEN Recent Development
4.9 Myriad RBM
4.9.1 Myriad RBM Corporation Information
4.9.2 Myriad RBM Description, Business Overview
4.9.3 Myriad RBM Neurological Biomarkers Products Offered
4.9.4 Myriad RBM Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
4.9.5 Myriad RBM Neurological Biomarkers Revenue by Product
4.9.6 Myriad RBM Neurological Biomarkers Revenue by Application
4.9.7 Myriad RBM Neurological Biomarkers Revenue by Geographic Area
4.9.8 Myriad RBM Recent Development
4.10 Cisbio Bioassays
4.10.1 Cisbio Bioassays Corporation Information
4.10.2 Cisbio Bioassays Description, Business Overview
4.10.3 Cisbio Bioassays Neurological Biomarkers Products Offered
4.10.4 Cisbio Bioassays Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
4.10.5 Cisbio Bioassays Neurological Biomarkers Revenue by Product
4.10.6 Cisbio Bioassays Neurological Biomarkers Revenue by Application
4.10.7 Cisbio Bioassays Neurological Biomarkers Revenue by Geographic Area
4.10.8 Cisbio Bioassays Recent Development
4.11 Athena Diagnostics
4.11.1 Athena Diagnostics Corporation Information
4.11.2 Athena Diagnostics Description, Business Overview
4.11.3 Athena Diagnostics Neurological Biomarkers Products Offered
4.11.4 Athena Diagnostics Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
4.11.5 Athena Diagnostics Neurological Biomarkers Revenue by Product
4.11.6 Athena Diagnostics Neurological Biomarkers Revenue by Application
4.11.7 Athena Diagnostics Neurological Biomarkers Revenue by Geographic Area
4.11.8 Athena Diagnostics Recent Development
4.12 BGI
4.12.1 BGI Corporation Information
4.12.2 BGI Description, Business Overview
4.12.3 BGI Neurological Biomarkers Products Offered
4.12.4 BGI Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
4.12.5 BGI Neurological Biomarkers Revenue by Product
4.12.6 BGI Neurological Biomarkers Revenue by Application
4.12.7 BGI Neurological Biomarkers Revenue by Geographic Area
4.12.8 BGI Recent Development
4.13 Wuxi APP
4.13.1 Wuxi APP Corporation Information
4.13.2 Wuxi APP Description, Business Overview
4.13.3 Wuxi APP Neurological Biomarkers Products Offered
4.13.4 Wuxi APP Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
4.13.5 Wuxi APP Neurological Biomarkers Revenue by Product
4.13.6 Wuxi APP Neurological Biomarkers Revenue by Application
4.13.7 Wuxi APP Neurological Biomarkers Revenue by Geographic Area
4.13.8 Wuxi APP Recent Development
4.14 Aepodia
4.14.1 Aepodia Corporation Information
4.14.2 Aepodia Description, Business Overview
4.14.3 Aepodia Neurological Biomarkers Products Offered
4.14.4 Aepodia Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
4.14.5 Aepodia Neurological Biomarkers Revenue by Product
4.14.6 Aepodia Neurological Biomarkers Revenue by Application
4.14.7 Aepodia Neurological Biomarkers Revenue by Geographic Area
4.14.8 Aepodia Recent Development
4.15 Proteome Sciences
4.15.1 Proteome Sciences Corporation Information
4.15.2 Proteome Sciences Description, Business Overview
4.15.3 Proteome Sciences Neurological Biomarkers Products Offered
4.15.4 Proteome Sciences Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
4.15.5 Proteome Sciences Neurological Biomarkers Revenue by Product
4.15.6 Proteome Sciences Neurological Biomarkers Revenue by Application
4.15.7 Proteome Sciences Neurological Biomarkers Revenue by Geographic Area
4.15.8 Proteome Sciences Recent Development
4.16 Genewiz
4.16.1 Genewiz Corporation Information
4.16.2 Genewiz Description, Business Overview
4.16.3 Genewiz Neurological Biomarkers Products Offered
4.16.4 Genewiz Neurological Biomarkers Sales, Revenue and Gross Margin (2015-2020)
4.16.5 Genewiz Neurological Biomarkers Revenue by Product
4.16.6 Genewiz Neurological Biomarkers Revenue by Application
4.16.7 Genewiz Neurological Biomarkers Revenue by Geographic Area
4.16.8 Genewiz Recent Development

5 Breakdown Data by Type
5.1 Global Neurological Biomarkers Sales by Type (2015-2026)
5.1.1 Global Neurological Biomarkers Sales by Type (2015-2020)
5.1.2 Global Neurological Biomarkers Sales Forecast by Type (2021-2026)
5.1.3 Global Neurological Biomarkers Sales Market Share by Type (2015-2026)
5.2 Global Neurological Biomarkers Revenue Forecast by Type (2015-2026)
5.2.1 Global Neurological Biomarkers Revenue by Type (2015-2020)
5.2.2 Global Neurological Biomarkers Revenue Forecast by Type (2021-2026)
5.2.3 Global Neurological Biomarkers Revenue Market Share by Type (2015-2026)
5.3 Neurological Biomarkers Average Selling Price (ASP) by Type (2015-2026)
6 Breakdown Data by Application
6.1 Global Neurological Biomarkers Sales by Application (2015-2026)
6.1.1 Global Neurological Biomarkers Sales by Application (2015-2020)
6.1.2 Global Neurological Biomarkers Sales Forecast by Application (2021-2026)
6.1.3 Global Neurological Biomarkers Sales Market Share by Application (2015-2026)
6.2 Global Neurological Biomarkers Revenue Forecast by Application (2015-2026)
6.2.1 Global Neurological Biomarkers Revenue by Application (2015-2020)
6.2.2 Global Neurological Biomarkers Revenue Forecast by Application (2021-2026)
6.2.3 Global Neurological Biomarkers Revenue Market Share by Application (2015-2026)
6.3 Neurological Biomarkers Average Selling Price (ASP) by Application (2015-2026)

7 North America
7.1 North America Neurological Biomarkers Market Size YoY Growth 2015-2026
7.2 North America Neurological Biomarkers Market Facts & Figures by Country
7.2.1 North America Neurological Biomarkers Sales by Country (2015-2026)
7.2.2 North America Neurological Biomarkers Revenue by Country (2015-2026)
7.3 North America Neurological Biomarkers Sales by Type
7.4 North America Neurological Biomarkers Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Neurological Biomarkers Market Size YoY Growth 2015-2026
8.2 Asia-Pacific Neurological Biomarkers Market Facts & Figures by Region
8.2.1 Asia-Pacific Neurological Biomarkers Sales by Region (2015-2026)
8.2.2 Asia-Pacific Neurological Biomarkers Revenue by Region (2015-2026)
8.3 Asia-Pacific Neurological Biomarkers Sales by Type
8.4 Asia-Pacific Neurological Biomarkers Sales by Application
9 Europe
9.1 Europe Neurological Biomarkers Market Size YoY Growth 2015-2026
9.2 Europe Neurological Biomarkers Market Facts & Figures by Country
9.2.1 Europe Neurological Biomarkers Sales by Country (2015-2026)
9.2.2 Europe Neurological Biomarkers Revenue by Country (2015-2026)
9.3 Europe Neurological Biomarkers Sales by Type
9.4 Europe Neurological Biomarkers Sales by Application
10 Latin America
10.1 Latin America Neurological Biomarkers Market Size YoY Growth 2015-2026
10.2 Latin America Neurological Biomarkers Market Facts & Figures by Country
10.2.1 Latin America Neurological Biomarkers Sales by Country (2015-2026)
10.2.2 Latin America Neurological Biomarkers Revenue by Country (2015-2026)
10.3 Latin America Neurological Biomarkers Sales by Type
10.4 Latin America Neurological Biomarkers Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Neurological Biomarkers Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Neurological Biomarkers Market Facts & Figures by Country
11.2.1 Middle East and Africa Neurological Biomarkers Sales by Country (2015-2026)
11.2.2 Middle East and Africa Neurological Biomarkers Revenue by Country (2015-2026)
11.3 Middle East and Africa Neurological Biomarkers Sales by Type
11.4 Middle East and Africa Neurological Biomarkers Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Neurological Biomarkers Supply Chain Analysis
12.2 Neurological Biomarkers Key Raw Materials and Upstream Suppliers
12.3 Neurological Biomarkers Clients Analysis
12.4 Neurological Biomarkers Sales Channel and Sales Model Analysis
12.4.1 Neurological Biomarkers Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Neurological Biomarkers Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Neurological Biomarkers Distributors
13 Market Dynamics
13.1 Neurological Biomarkers Market Drivers
13.2 Neurological Biomarkers Market Opportunities
13.3 Neurological Biomarkers Market Challenges
13.4 Neurological Biomarkers Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables

Table 1. Global Neurological Biomarkers Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 2. Major Manufacturers of Proteomics

Table 3. Major Manufacturers of Genomics

Table 4. Major Manufacturers of Imaging

Table 5. Major Manufacturers of Bioinformatics

Table 6. Major Manufacturers of Others

Table 7. Global Neurological Biomarkers Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 8. Global Neurological Biomarkers Market Size by Region (US$ Million): 2020 VS 2026

Table 9. Global Neurological Biomarkers Sales by Region (2015-2020) & (K Units)

Table 10. Global Neurological Biomarkers Sales Forecast by Region (2021-2026) & (K Units)

Table 11. Global Neurological Biomarkers Revenue by Region (2015-2020) & (US$ Million)

Table 12. Global Neurological Biomarkers Revenue Forecast by Region (2021-2026) & (US$ Million)

Table 13. Global Neurological Biomarkers Sales by Manufacturer (2015-2020) & (K Units)

Table 14. Global Neurological Biomarkers Sales Share by Manufacturer (2015-2020)

Table 15. Neurological Biomarkers Revenue by Manufacturer (2015-2020) & (US$ Million)

Table 16. Neurological Biomarkers Revenue Share by Manufacturer (2015-2020)

Table 17. Key Manufacturers Neurological Biomarkers Price (2015-2020) & (USD/Unit)

Table 18. Ranking of Global Top Neurological Biomarkers Manufacturers by Revenue (US$ Million) in 2019

Table 19. Global Neurological Biomarkers Manufacturers Market Concentration Ratio (CR5 and HHI) & (2015-2020)

Table 20. Global Neurological Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neurological Biomarkers as of 2019)

Table 21. Neurological Biomarkers Manufacturers Manufacturing Base Distribution and Headquarters

Table 22. Manufacturers Neurological Biomarkers Product Type

Table 23. Date of International Manufacturers Enter into Neurological Biomarkers Market

Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 25. Thermo Fisher Scientific Corporation Information

Table 26. Thermo Fisher Scientific Description and Business Overview

Table 27. Thermo Fisher Scientific Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 28. Thermo Fisher Scientific Neurological Biomarkers Product

Table 29. Thermo Fisher Scientific Neurological Biomarkers Revenue (US$ Million) and Market Share by Product

Table 30. Thermo Fisher Scientific Neurological Biomarkers Revenue (US$ Million) and Market Share by Application

Table 31. Thermo Fisher Scientific Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area

Table 32. Thermo Fisher Scientific Neurological Biomarkers Revenue (US$ Million) and Market Share by Sales Channel

Table 33. Thermo Fisher Scientific Recent Development

Table 34. Merck Corporation Information

Table 35. Merck Description and Business Overview

Table 36. Merck Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 37. Merck Neurological Biomarkers Product

Table 38. Merck Neurological Biomarkers Revenue (US$ Million) and Market Share by Product

Table 39. Merck Neurological Biomarkers Revenue (US$ Million) and Market Share by Application

Table 40. Merck Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area

Table 41. Merck Neurological Biomarkers Revenue (US$ Million) and Market Share by Sales Channel

Table 42. Merck Recent Development

Table 43. Quest Diagnostics Corporation Information

Table 44. Quest Diagnostics Description and Business Overview

Table 45. Quest Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 46. Quest Diagnostics Neurological Biomarkers Product

Table 47. Quest Diagnostics Neurological Biomarkers Revenue (US$ Million) and Market Share by Product

Table 48. Quest Diagnostics Neurological Biomarkers Revenue (US$ Million) and Market Share by Application

Table 49. Quest Diagnostics Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area

Table 50. Quest Diagnostics Neurological Biomarkers Revenue (US$ Million) and Market Share by Sales Channel

Table 51. Quest Diagnostics Recent Development

Table 52. Abbott Corporation Information

Table 53. Abbott Description and Business Overview

Table 54. Abbott Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 55. Abbott Neurological Biomarkers Product

Table 56. Abbott Neurological Biomarkers Revenue (US$ Million) and Market Share by Product

Table 57. Abbott Neurological Biomarkers Revenue (US$ Million) and Market Share by Application

Table 58. Abbott Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area

Table 59. Abbott Neurological Biomarkers Revenue (US$ Million) and Market Share by Sales Channel

Table 60. Abbott Recent Development

Table 61. Roche Corporation Information

Table 62. Roche Description and Business Overview

Table 63. Roche Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 64. Roche Neurological Biomarkers Product

Table 65. Roche Neurological Biomarkers Revenue (US$ Million) and Market Share by Product

Table 66. Roche Neurological Biomarkers Revenue (US$ Million) and Market Share by Application

Table 67. Roche Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area

Table 68. Roche Neurological Biomarkers Revenue (US$ Million) and Market Share by Sales Channel

Table 69. Roche Recent Development

Table 70. Illumina Corporation Information

Table 71. Illumina Description and Business Overview

Table 72. Illumina Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 73. Illumina Neurological Biomarkers Product

Table 74. Illumina Neurological Biomarkers Revenue (US$ Million) and Market Share by Product

Table 75. Illumina Neurological Biomarkers Revenue (US$ Million) and Market Share by Application

Table 76. Illumina Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area

Table 77. Illumina Recent Development

Table 78. Bio-Rad Laboratories Corporation Information

Table 79. Bio-Rad Laboratories Description and Business Overview

Table 80. Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 81. Bio-Rad Laboratories Neurological Biomarkers Product

Table 82. Bio-Rad Laboratories Neurological Biomarkers Revenue (US$ Million) and Market Share by Product

Table 83. Bio-Rad Laboratories Neurological Biomarkers Revenue (US$ Million) and Market Share by Application

Table 84. Bio-Rad Laboratories Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area

Table 85. Bio-Rad Laboratories Recent Development

Table 86. QIAGEN Corporation Information

Table 87. QIAGEN Description and Business Overview

Table 88. QIAGEN Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 89. QIAGEN Neurological Biomarkers Product

Table 90. QIAGEN Neurological Biomarkers Revenue (US$ Million) and Market Share by Product

Table 91. QIAGEN Neurological Biomarkers Revenue (US$ Million) and Market Share by Application

Table 92. QIAGEN Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area

Table 93. QIAGEN Recent Development

Table 94. Myriad RBM Corporation Information

Table 95. Myriad RBM Description and Business Overview

Table 96. Myriad RBM Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 97. Myriad RBM Neurological Biomarkers Product

Table 98. Myriad RBM Neurological Biomarkers Revenue (US$ Million) and Market Share by Product

Table 99. Myriad RBM Neurological Biomarkers Revenue (US$ Million) and Market Share by Application

Table 100. Myriad RBM Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area

Table 101. Myriad RBM Recent Development

Table 102. Cisbio Bioassays Corporation Information

Table 103. Cisbio Bioassays Description and Business Overview

Table 104. Cisbio Bioassays Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 105. Cisbio Bioassays Neurological Biomarkers Product

Table 106. Cisbio Bioassays Neurological Biomarkers Revenue (US$ Million) and Market Share by Product

Table 107. Cisbio Bioassays Neurological Biomarkers Revenue (US$ Million) and Market Share by Application

Table 108. Cisbio Bioassays Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area

Table 109. Cisbio Bioassays Recent Development

Table 110. Athena Diagnostics Corporation Information

Table 111. Athena Diagnostics Description and Business Overview

Table 112. Athena Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 113. Athena Diagnostics Neurological Biomarkers Product

Table 114. Athena Diagnostics Neurological Biomarkers Revenue (US$ Million) and Market Share by Product

Table 115. Athena Diagnostics Neurological Biomarkers Revenue (US$ Million) and Market Share by Application

Table 116. Athena Diagnostics Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area

Table 117. Athena Diagnostics Recent Development

Table 118. BGI Corporation Information

Table 119. BGI Description and Business Overview

Table 120. BGI Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 121. BGI Neurological Biomarkers Product

Table 122. BGI Neurological Biomarkers Revenue (US$ Million) and Market Share by Product

Table 123. BGI Neurological Biomarkers Revenue (US$ Million) and Market Share by Application

Table 124. BGI Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area

Table 125. BGI Recent Development

Table 126. Wuxi APP Corporation Information

Table 127. Wuxi APP Description and Business Overview

Table 128. Wuxi APP Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 129. Wuxi APP Neurological Biomarkers Product

Table 130. Wuxi APP Neurological Biomarkers Revenue (US$ Million) and Market Share by Product

Table 131. Wuxi APP Neurological Biomarkers Revenue (US$ Million) and Market Share by Application

Table 132. Wuxi APP Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area

Table 133. Wuxi APP Recent Development

Table 134. Aepodia Corporation Information

Table 135. Aepodia Description and Business Overview

Table 136. Aepodia Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 137. Aepodia Neurological Biomarkers Product

Table 138. Aepodia Neurological Biomarkers Revenue (US$ Million) and Market Share by Product

Table 139. Aepodia Neurological Biomarkers Revenue (US$ Million) and Market Share by Application

Table 140. Aepodia Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area

Table 141. Aepodia Recent Development

Table 142. Proteome Sciences Corporation Information

Table 143. Proteome Sciences Description and Business Overview

Table 144. Proteome Sciences Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 145. Proteome Sciences Neurological Biomarkers Product

Table 146. Proteome Sciences Neurological Biomarkers Revenue (US$ Million) and Market Share by Product

Table 147. Proteome Sciences Neurological Biomarkers Revenue (US$ Million) and Market Share by Application

Table 148. Proteome Sciences Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area

Table 149. Proteome Sciences Recent Development

Table 150. Genewiz Corporation Information

Table 151. Genewiz Description and Business Overview

Table 152. Genewiz Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 153. Genewiz Neurological Biomarkers Product

Table 154. Genewiz Neurological Biomarkers Revenue (US$ Million) and Market Share by Product

Table 155. Genewiz Neurological Biomarkers Revenue (US$ Million) and Market Share by Application

Table 156. Genewiz Neurological Biomarkers Revenue (US$ Million) and Market Share by Geographic Area

Table 157. Genewiz Recent Development

Table 158. Global Neurological Biomarkers Sales by Type (2015-2020) & (K Units)

Table 159. Global Neurological Biomarkers Sales Forecast by Type (2021-2026) & (K Units)

Table 160. Global Neurological Biomarkers Revenue by Type (2015-2020) & (US$ Million)

Table 161. Global Neurological Biomarkers Revenue Forecast by Type (2021-2026) & (US$ Million)

Table 162. Global Neurological Biomarkers Sales by Application (2015-2020) & (K Units)

Table 163. Global Neurological Biomarkers Sales Forecast by Application (2021-2026) & (K Units)

Table 164. Global Neurological Biomarkers Revenue by Application (2015-2020) & (US$ Million)

Table 165. Global Neurological Biomarkers Revenue Forecast by Application (2021-2026) & (US$ Million)

Table 166. North America Neurological Biomarkers Sales by Country (2015-2020) & (K Units)

Table 167. North America Neurological Biomarkers Sales by Country (2021-2026) & (K Units)

Table 168. North America Neurological Biomarkers Revenue by Country (2015-2020) & (US$ Million)

Table 169. North America Neurological Biomarkers Revenue by Country (2021-2026) & (US$ Million)

Table 170. North America Neurological Biomarkers Sales by Type (2015-2020) & (K Units)

Table 171. North America Neurological Biomarkers Sales by Application (2015-2020) & (K Units)

Table 172. Asia-Pacific Neurological Biomarkers Sales by Region (2015-2020) & (K Units)

Table 173. Asia-Pacific Neurological Biomarkers Sales by Region (2021-2026) & (K Units)

Table 174. Asia-Pacific Neurological Biomarkers Revenue by Region (2015-2026) & (US$ Million)

Table 175. Asia-Pacific Neurological Biomarkers Revenue by Region (2021-2026) & (US$ Million)

Table 176. Asia-Pacific Neurological Biomarkers Sales by Type (2015-2020) & (K Units)

Table 177. Asia-Pacific Neurological Biomarkers Sales by Application (2015-2020) & (K Units)

Table 178. Europe Neurological Biomarkers Sales by Country (2015-2020) & (K Units)

Table 179. Europe Neurological Biomarkers Sales by Country (2021-2026) & (K Units)

Table 180. Europe Neurological Biomarkers Revenue by Country (2015-2020) & (US$ Million)

Table 181. Europe Neurological Biomarkers Revenue by Country (2021-2026) & (US$ Million)

Table 182. Europe Neurological Biomarkers Sales by Type (2015-2020) & (K Units)

Table 183. Europe Neurological Biomarkers Sales by Application (2015-2020) & (K Units)

Table 184. Latin America Neurological Biomarkers Sales by Country (2015-2020) & (K Units)

Table 185. Latin America Neurological Biomarkers Sales by Country (2021-2026) & (K Units)

Table 186. Latin America Neurological Biomarkers Revenue by Country (2015-2020) & (US$ Million)

Table 187. Latin America Neurological Biomarkers Revenue by Country (2021-2026) & (US$ Million)

Table 188. Latin America Neurological Biomarkers Sales by Type (2015-2020) & (K Units)

Table 189. Latin America Neurological Biomarkers Sales by Application (2015-2020) & (K Units)

Table 190. Middle East and Africa Neurological Biomarkers Sales by Country (2015-2020) & (K Units)

Table 191. Middle East and Africa Neurological Biomarkers Sales by Country (2021-2026) & (K Units)

Table 192. Middle East and Africa Neurological Biomarkers Revenue by Country (2015-2020) & (US$ Million)

Table 193. Middle East and Africa Neurological Biomarkers Revenue by Country (2021-2026) & (US$ Million)

Table 194. Middle East and Africa Neurological Biomarkers Sales by Type (2015-2020) & (K Units)

Table 195. Middle East and Africa Neurological Biomarkers Sales by Application (2015-2020) & (K Units)

Table 196. Neurological Biomarkers Key Raw Materials, Industry Status and Trend

Table 197. Neurological Biomarkers Key Raw Materials and Upstream Suppliers

Table 198. Neurological Biomarkers Clients Status and Trend

Table 199. Neurological Biomarkers Typical Clients

Table 200. Neurological Biomarkers Distributors

Table 201. Key Drivers: Impact Analysis (2021-2026)

Table 202. Neurological Biomarkers Market Drivers

Table 203. Neurological Biomarkers Market Opportunities

Table 204. Neurological Biomarkers Market Challenges

Table 205. Neurological Biomarkers Market Restraints

Table 206. Neurological Biomarkers Porter?s Five Forces Analysis

Table 207. Research Programs/Design for This Report

Table 208. Key Data Information from Secondary Sources

Table 209. Key Data Information from Primary Sources

List of Figures

Figure 1. Neurological Biomarkers Product Picture

Figure 2. Global Neurological Biomarkers Sales Market Share by Type in 2020 & 2026

Figure 3. Proteomics Product Picture

Figure 4. Genomics Product Picture

Figure 5. Imaging Product Picture

Figure 6. Bioinformatics Product Picture

Figure 7. Others Product Picture

Figure 8. Global Neurological Biomarkers Sales Market Share by Application in 2020 & 2026

Figure 9. Diagnostics Examples

Figure 10. Drug Discovery Examples

Figure 11. Personalized Medicine Examples

Figure 12. Others Examples

Figure 13. Neurological Biomarkers Report Years Considered

Figure 14. Global Neurological Biomarkers Market Size, (US$ Million), 2015 VS 2020 VS 2026

Figure 15. Global Neurological Biomarkers Market Size 2015-2026 (US$ Million)

Figure 16. Global Neurological Biomarkers Sales 2015-2026 (K Units)

Figure 17. Global Neurological Biomarkers Market Size Market Share by Region: 2020 Versus 2026

Figure 18. Global Neurological Biomarkers Sales Market Share Forecast by Region (2015-2026)

Figure 19. Global Neurological Biomarkers Revenue Market Share by Region (2015-2026)

Figure 20. Global Neurological Biomarkers Sales Share by Manufacturer in 2019

Figure 21. Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 22. Global Neurological Biomarkers Sales Market Share Forecast by Type (2015-2026)

Figure 23. Global Neurological Biomarkers Revenue Market Share Forecast by Type (2015-2026)

Figure 24. Neurological Biomarkers Average Selling Price (ASP) by Type (2015-2020) & (USD/Unit)

Figure 25. Global Neurological Biomarkers Sales Market Share Forecast by Application (2015-2026)

Figure 26. Global Neurological Biomarkers Revenue Market Share Forecast by Application (2015-2026)

Figure 27. Neurological Biomarkers Average Selling Price (ASP) by Application (2015-2020) & (USD/Unit)

Figure 28. North America Neurological Biomarkers Revenue 2015-2026 (US$ Million)

Figure 29. North America Neurological Biomarkers Sales Market Share by Type (2015-2020)

Figure 30. North America Neurological Biomarkers Sales Market Share by Application (2015-2020)

Figure 31. Asia-Pacific Neurological Biomarkers Revenue 2015-2026 (US$ Million)

Figure 32. Asia-Pacific Neurological Biomarkers Sales Market Share by Region (2015-2026)

Figure 33. Asia-Pacific Neurological Biomarkers Revenue Market Share by Region (2015-2026)

Figure 34. Asia-Pacific Neurological Biomarkers Sales Market Share by Type (2015-2020)

Figure 35. Asia-Pacific Neurological Biomarkers Sales Market Share by Application (2015-2020)

Figure 36. Europe Neurological Biomarkers Revenue Growth Rate 2015-2026 (US$ Million)

Figure 37. Europe Neurological Biomarkers Sales Market Share by Country (2015-2026)

Figure 38. Europe Neurological Biomarkers Revenue Market Share by Country (2015-2026)

Figure 39. Europe Neurological Biomarkers Sales Market Share by Type (2015-2020)

Figure 40. Europe Neurological Biomarkers Sales Market Share by Application (2015-2020)

Figure 41. Latin America Neurological Biomarkers Revenue Growth Rate 2015-2026 (US$ Million)

Figure 42. Latin America Neurological Biomarkers Sales Market Share by Country (2015-2026)

Figure 43. Latin America Neurological Biomarkers Revenue Market Share by Country (2015-2020)

Figure 44. Latin America Neurological Biomarkers Sales Market Share by Type (2015-2020)

Figure 45. Latin America Neurological Biomarkers Sales Market Share by Application (2015-2020)

Figure 46. Middle East and Africa Neurological Biomarkers Revenue Growth Rate 2015-2026 (US$ Million)

Figure 47. Middle East and Africa Neurological Biomarkers Sales Market Share by Country (2015-2026)

Figure 48. Middle East and Africa Neurological Biomarkers Revenue Market Share by Country (2015-2026)

Figure 49. Middle East and Africa Neurological Biomarkers Sales Market Share by Type (2015-2020)

Figure 50. Middle East and Africa Neurological Biomarkers Sales Market Share by Application (2015-2020)

Figure 51. Neurological Biomarkers Supply Chain (Upstream and Downstream Market)

Figure 52. Global Production Market Share of Neurological Biomarkers Raw Materials by Region in 2019

Figure 53. Neurological Biomarkers Distribution Channels

Figure 54. Global Neurological Biomarkers Percentage 2015-2026: Indirect Sales VS Direct Sales

Figure 55. Global Neurological Biomarkers Percentage 2015-2026: Online Sales VS Offline Sales

Figure 56. Porter's Five Forces Analysis

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

Thermo Fisher Scientific

Merck

Quest Diagnostics

Abbott

Roche

Illumina

Bio-Rad Laboratories

QIAGEN

Myriad RBM

Cisbio Bioassays

Athena Diagnostics

BGI

Wuxi APP

Aepodia

Proteome Sciences

Genewiz

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $4602

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase